Today: 19 May 2026
Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes
30 December 2025
2 mins read

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

NEW YORK, December 29, 2025, 21:23 ET — Market closed

  • Synopsys shares rose 0.4% to $478.97 on Monday, outperforming a softer Nasdaq session.
  • Investor-law firms flagged a Dec. 30 deadline tied to a securities class-action case involving Synopsys.
  • Markets’ next test is Tuesday’s Fed minutes and key U.S. data in thin year-end trading.

Synopsys shares ended Monday up 0.4% at $478.97, holding gains into the close even as broader U.S. stocks slipped in holiday-thinned trading.

The chip-design software maker is closely watched because its electronic design automation (EDA) tools—software used to design and test chips—sit early in the semiconductor supply chain and tend to reflect demand for next-generation computing.

The timing matters. U.S. markets are heading into the final days of the year with light liquidity, while investors await the Federal Reserve’s December meeting minutes on Tuesday for clues on the 2026 rate path.

Synopsys traded between $471.28 and $484.33 during the session, with about 1.33 million shares changing hands, according to market data.

The stock outperformed parts of the tech complex. The Invesco QQQ Trust—an ETF tracking the Nasdaq-100—fell 0.5% on the day, while the iShares Semiconductor ETF was slightly lower.

In the EDA group, rival Cadence Design Systems slipped about 0.4%, while Nvidia—one of Synopsys’ key partners and a bellwether for AI-linked spending—fell about 1.2%.

Company-specific headlines were limited, but several investor-law firms circulated reminders on Monday about a securities class-action lawsuit and a Dec. 30 deadline for investors seeking to be appointed lead plaintiff. In one notice, Levi & Korsinsky said the complaint concerns alleged misstatements tied to the company’s Design IP business and related economics.

Synopsys has faced heightened scrutiny since a sharp selloff earlier this year. In September, the company’s shares sank after the company disclosed a quarterly revenue miss and warned about China-related pressures, Reuters reported at the time.

Investors have largely shifted focus back to execution and guidance. Synopsys said on Dec. 10 it expects fiscal 2026 revenue of about $9.61 billion at the midpoint, including roughly $2.9 billion of expected Ansys revenue, and forecast first-quarter revenue of $2.365 billion to $2.415 billion for the period ending Jan. 31, 2026.

“The Synopsys team delivered a solid finish to a year that redefined our company as the leader in engineering solutions from silicon to systems,” CEO Sassine Ghazi said in the company’s December results statement. Synopsys Investor Relations

Before Tuesday’s session, traders will watch U.S. data on home prices and business activity, followed by the Fed minutes at 2:00 p.m. ET—events that can sway rate expectations and, by extension, valuations for growth stocks such as software and chip-design names.

The near-term tape has clear markers. A break below Monday’s low near $471 would put the late-December rebound under pressure, while a push back through the $484 area would leave the stock testing recent resistance. Beyond the next session, investors are likely to focus on any updates tied to litigation headlines and Synopsys’ ability to meet its first-quarter targets as it integrates Ansys and navigates export-control assumptions embedded in its outlook.

Stock Market Today

  • 8x8 Beats Q1 Sales Estimates, Shares Surge 15%
    May 19, 2026, 5:24 PM EDT. Cloud communications firm 8x8 (NASDAQ:EGHT) reported Q1 CY2026 revenue of $185.2 million, 4.6% higher year-on-year and surpassing analysts' $181.1 million estimate. Adjusted earnings per share stood at $0.11, beating the consensus by 41.9%. The company forecasted Q2 revenue of $182.5 million, aligning with market expectations. Operating margin expanded to 1.8% from 0.2% last year, while free cash flow margin declined to 6.1%. CEO Samuel Wilson highlighted four consecutive quarters of revenue growth and the first GAAP profit since 2015. Despite short-term strength, 8x8's long-term revenue growth remains modest, with analysts projecting flat sales over the next year. Market cap reached $333 million following a 15% stock rise.

Latest articles

SMCI Stock Alert: Super Micro Slips as Sales Shake-Up Tests AI Server Rally

SMCI Stock Alert: Super Micro Slips as Sales Shake-Up Tests AI Server Rally

19 May 2026
Super Micro Computer shares fell 0.9% to $30.56 Tuesday after a filing showed longtime sales chief Don Clegg retired, effective May 15. The company named Matthew Thauberger as chief revenue officer last week. Super Micro reported third-quarter net sales of $10.2 billion, up from $4.6 billion a year earlier, but missed Wall Street revenue estimates.
Keysight Shares Surge as Orders Hit Record High

Keysight Shares Surge as Orders Hit Record High

19 May 2026
Keysight Technologies shares climbed nearly 4% in after-hours trading Tuesday after reporting fiscal Q2 revenue of $1.72 billion and adjusted earnings of $2.87 per share, beating analyst estimates. Orders rose to $2.05 billion from $1.32 billion a year earlier. The stock closed at $344.11, then traded at $357.80 after the bell. S&P 500 and Nasdaq both fell during the session.
AMD Stock Just Slipped Before Nvidia’s Big Test — Here’s What Changed

AMD Stock Just Slipped Before Nvidia’s Big Test — Here’s What Changed

19 May 2026
AMD shares fell 1.6% to $414.05 Tuesday after a volatile session, as investors trimmed chip stock holdings ahead of Nvidia’s earnings and rising Treasury yields pressured tech names. Citi raised its AMD price target to $460 but maintained a Neutral rating. Nvidia, down 0.7%, will report results Wednesday, with options implying a $355 billion market value swing. Intel rose 2.4%.
Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs
Previous Story

Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 30.12.2025

Go toTop